Inosan Biopharma

Building Trust, Ensuring Safety for a Confident Tomorrow

[Inosan Biopharma @InosanBiopharma]

Read more on:

https://t.co/3gEQxfStqK

#Inosan #BuildingTrust

[Inosan Biopharma @InosanBiopharma]

Inoserp™ Pan-Africa provides very broad coverage of medically important species in sub-Saharan Africa. This review presents all available clinical data on the use of Inoserp™ PAN- AFRICA in sub-Saharan Africa since its introduction in 2012.

Link: https://t.co/syauvjXnqB

[Inosan Biopharma @InosanBiopharma]

This is the largest multicenter clinical study performed with Inoserp PAN-AFRICA and one of the largest antivenom study conducted in sub-Saharan Africa (447 patients).

#BuildingTrust #Inosan

https://t.co/zxTUMHzrq5

[Inosan Biopharma @InosanBiopharma]

Inosan's therapeutic approach for the treatment of snake envenomation in Africa has shown a satisfactory safety and efficacy profile in several clinical studies conducted on the African continent.

#BuildingTrust #Inosan

https://t.co/eLVp9EESeH

[Inosan Biopharma @InosanBiopharma]

Learn more about our products, visit our website!
https://t.co/dfIYbyk4A4
#BuildingTrust #Inosan

[Inosan Biopharma @InosanBiopharma]

#InosanBiopharma

[Inosan Biopharma @InosanBiopharma]

Go to https://t.co/EXevU05mCH to learn more!

Buy your ticket before they sell out!

[Inosan Biopharma @InosanBiopharma]

Go to https://t.co/xyHIL8ecai… to learn more!

Buy your ticket before they sell out!

[Inosan Biopharma @InosanBiopharma]

Go to https://t.co/dTBshTSBxB to learn more!

Buy your ticket before they sell out!

[Inosan Biopharma @InosanBiopharma]

Antivenom manufacturing is a complex process. At Inosan we take pride on our production platform meeting the highest quality standards to create products that can be used in every region of the world thanks to its freeze-dried technology, polyvalence and reproducibility.

[Inosan Biopharma @InosanBiopharma]

We are proud to be recognized by @PCuresResearch as an important investor in research and development of solutions against snakebite envenoming

https://t.co/AZG2RtuxRA

[Inosan Biopharma @InosanBiopharma]

to drive medical and biomedical research and innovation for neglected health issues. We believe that team work can bring better solutions for communities in risk of animal envenoming, and this collaborations can help making this NTD more visible.

https://t.co/AZG2RtuxRA

[Inosan Biopharma @InosanBiopharma]

Thanks to Policy Cures Research for recognizing Inosan’s efforts in R&D of antibodies. Policy Cures Research is a global organization improving the health of the world’s most disadvantaged people by using evidence...

[Inosan Biopharma @InosanBiopharma]

Extreme Procoagulant Potency in Human Plasma of Venoms from the African Viperid Genera Atheris, Cerastes, and Proatheris and the Relative Efficacy of Antivenoms and Synthetic Enzyme-Inhibitors, Chowdhury et Al, Toxins 2022. https://t.co/SN0BEn7Ckp

[Inosan Biopharma @InosanBiopharma]

A recent study has shown that InoserpTM MENA was the only antivenom able to effectively neutralize the venom of Cerastes species, in comparison to other snake antivenoms tested.

[Inosan Biopharma @InosanBiopharma]

This study was carried out by the “Venom Evolution Lab” of the University of Queensland in Australia.

[Inosan Biopharma @InosanBiopharma]

¡Feliz día, químicos!

[Inosan Biopharma @InosanBiopharma]

#TB Inosan Biopharma at the IST in Abu Dhabi with many interactions with researchers and clinicians from all over the world to fight animal envenoming. Great opportunity to present the neutralization profile of Inoserp™️ MENA and Inoscorpi™️ MENA, snakes and scorpions antivenoms.